BSEBoard MeetingResults3 Aug 2026
Park Medi World Ltd
Standalone and Consolidated Financial Results for the Quarter ended 30 June 2026
Park Medi World Ltd has announced its standalone and consolidated financial results for the quarter ended June 30, 2026, and has also approved the acquisition of Mehar Hospital-Zirakpur, and variation in the objects of the Initial Public Offer Proceeds.
BSEResultResults3 Aug 2026
Park Medi World Ltd
Standalone and Consolidated Results for the Quarter ended 30 June 2026
Park Medi World Ltd has announced its standalone and consolidated results for the quarter ended June 30, 2026, and has also approved the acquisition of Mehar Hospital-Zirakpur, owned and operated by Mehar Mediserve LLP. The company has also announced a variation in the objects of the Initial Public Offer Proceeds, subject to shareholder approval.
BSECompany Update▲ PositiveExpansion2 Aug 2026
Park Medi World Ltd
Launch of The Medicity Hospital, Rudrapur
Park Medi World Ltd has launched The Medicity Hospital, Rudrapur, a 330-bed multi-super specialty facility in Uttarakhand, expanding its operational presence to six states across North India.
BSECompany Update▲ PositiveM&A31 Jul 2026
Park Medi World Ltd
Update on the Acquisition of The Medicity Hospital, Rudrapur
Park Medi World Ltd has completed the acquisition of 80% shareholding of V3 Healthcare Private Limited, which operates The Medicity Hospital - Rudrapur, and has scheduled the hospital's launch for August 2, 2026.
BSECompany UpdateResults29 Jul 2026
Park Medi World Ltd
Schedule of Analyst/Investor Meeting
Park Medi World Ltd has announced a conference call for analysts and institutional investors to discuss its unaudited financial results for the quarter ended June 30, 2026.
BSEBoard MeetingResults29 Jul 2026
Park Medi World Ltd
Park Medi World Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/08/2026 ,inter alia, to consider and approve Standalone and Consolidated ....
Park Medi World Ltd has scheduled a board meeting on August 3, 2026, to consider and approve the standalone and consolidated unaudited financial results for the quarter ended June 30, 2026.